4//SEC Filing
Kunkel Lori Anne 4
Accession 0001536368-25-000007
CIK 0001672619other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:58 PM ET
Size
7.7 KB
Accession
0001536368-25-000007
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-17$1.12/sh+15,958$17,873→ 30,712 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-17−15,958→ 3,741 totalExercise: $1.12Exp: 2030-06-15→ Common Stock (15,958 underlying)
Holdings
- 31,172(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The shares are held by Lori Kunkel Revocable Trust DTD 11/08/2018 Lori A Kunkel TTEE.
- [F2]All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:58 PM ET
- Size
- 7.7 KB